Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Diseases

Explore clinical trials studying Respiratory Tract Diseases. Study availability and eligibility vary by location and protocol.

37,292 public trials 4,949 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Diseases trial results

Recruiting

The SEQUENCE Trial

NCT06676956

Conditions
Lung Diseases, Lung Neoplasms, Multiple Pulmonary Nodules, +6 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • University of California, Davis Sacramento, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details
Recruiting

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

NCT04165798

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0001) Gilbert, Arizona, United States
  • City of Hope ( Site 0014) Duarte, California, United States
  • UCSF Medical Center at Mission Bay ( Site 0007) San Francisco, California, United States
  • Georgetown University ( Site 0036) Washington D.C., District of Columbia, United States
View all 47 locations
View Trial Details
Recruiting

A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)

NCT07124078

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Children'S Hospital Los Angeles Specialt Los Angeles, California, United States
  • Lucile Packard Child Hospital End Palo Alto, California, United States
  • Childrens National Medical Center Washington D.C., District of Columbia, United States
View all 41 locations
View Trial Details
Recruiting

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

NCT04165070

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0001) Gilbert, Arizona, United States
  • City of Hope ( Site 0014) Duarte, California, United States
  • UCSF Medical Center at Mission Bay ( Site 0007) San Francisco, California, United States
  • Georgetown University ( Site 0036) Washington D.C., District of Columbia, United States
View all 46 locations
View Trial Details
Recruiting

Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)

NCT06780098

Conditions
Lung Diseases, Lung Neoplasm, Lung Neoplasms, +5 more
Locations
  • University of Kentucky Chandler Medical Center ( Site 0019) Lexington, Kentucky, United States
  • MedStar Franklin Square Medical Center ( Site 0033) Baltimore, Maryland, United States
  • Texas Oncology - DFW ( Site 8003) Dallas, Texas, United States
  • Centro de Estudios Clínicos SAGA ( Site 0161) Santiago, Region M. de Santiago, Chile
View all 44 locations
View Trial Details

Related conditions